Chi Sheng Pharma & Biotech Co., Ltd (TPEX:4111)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
29.35
-0.65 (-2.17%)
Mar 9, 2026, 1:30 PM CST
1.71%
Market Cap 1.76B
Revenue (ttm) 1.36B
Net Income (ttm) 165.35M
Shares Out 59.83M
EPS (ttm) 2.75
PE Ratio 10.69
Forward PE n/a
Dividend 0.95 (3.17%)
Ex-Dividend Date Aug 26, 2025
Volume 184,073
Average Volume 116,994
Open 29.85
Previous Close 30.00
Day's Range 29.25 - 29.85
52-Week Range 25.10 - 32.90
Beta 0.21
RSI 41.75
Earnings Date Mar 13, 2026

About TPEX:4111

Chi Sheng Pharma & Biotech Co., Ltd manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally. Its product portfolio includes antibiotics and chemotherapeutic agents; plasma substitutes and amino acid preparations; water nutrients and electrolyte preparations; vitamins; hepatotropic agents; hormones and adrenal cortical steroids; autonomic nerve agents; antihistamines and antipruritics; antipyretics and analgesics; antitussives and... [Read more]

Sector Healthcare
Founded 1962
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4111
Full Company Profile

Financial Performance

In 2024, TPEX:4111's revenue was 1.17 billion, an increase of 9.86% compared to the previous year's 1.06 billion. Earnings were 110.63 million, an increase of 61.10%.

Financial Statements

News

There is no news available yet.